ADAM17 and COVID-19: Therefore, by employing Mendelian randomization (MR), we aimed to investigate if there is a causal relationship between circulating ADAM17 (cytoplasmic and membrane-bound domains) and the risk of severe COVID-19, using the latest genome-wide association studies (GWAS) of ADAM17 [11] and COVID-19 [12].